Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000535:Aluminum / Q000009:adverse effects; D001007:Anxiety / Q000188:drug therapy; D002675:Child, Preschool; D002707:Chlordiazepoxide / Q000009:adverse effects* / Q000627:therapeutic use; D004622:Embryo, Mammalian / Q000187:drug effects*; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects*; D005984:Glutethimide / Q000009:adverse effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D006878:Hydroxides / Q000009:adverse effects; D007223:Infant; D007231:Infant, Newborn; D008274:Magnesium / Q000009:adverse effects; D008620:Meprobamate / Q000009:adverse effects* / Q000627:therapeutic use; D008694:Methamphetamine / Q000009:adverse effects; D010424:Pentobarbital / Q000009:adverse effects; D010634:Phenobarbital / Q000009:adverse effects; D010879:Piperazines / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D014815:Vitamins / Q000009:adverse effects
D006878:Hydroxides; D010879:Piperazines; D014815:Vitamins; D006852:Hydrochlorothiazide; D008694:Methamphetamine; D002707:Chlordiazepoxide; D008620:Meprobamate; D005984:Glutethimide; D000535:Aluminum; D008274:Magnesium; D010424:Pentobarbital; D010634:Phenobarbital